Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-09-27
1994-03-22
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514214, 540586, 546141, 546142, 546145, 546146, 546147, 546150, 546152, 546153, 546296, 546297, 546299, A61K 3155, C07D40106
Patent
active
052964833
ABSTRACT:
The subject compounds, which are adapted for the site-specific/sustained delivery of centrally acting drug species to the brain, are compounds of the formula ##STR1## and the non-toxic pharmaceutically acceptable salts thereof, wherein D is the residue of a centrally acting primary, secondary or tertiary amine and ##STR2## is an unsubstituted or substituted dihydropyridyl, dihydroquinolyl or dihydroisoquinolyl radical. The corresponding ionic pyridinium, quinolinium and isoquinolinium salts ##STR3## wherein X.sup.- is the anion of a non-toxic pharmaceutically acceptable acid, are also disclosed.
REFERENCES:
Thiel, et al., "Chemical Abstracts", vol. 59, 1963, Col. 6389e-6391a.
Ivy C. Warren
Turnipseed James H.
University of Florida
LandOfFree
Brain-specific analogues of centrally acting amines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Brain-specific analogues of centrally acting amines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Brain-specific analogues of centrally acting amines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437257